Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // March 7th, 2011 // 7:38 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
• Pharma Blog » 2011
Pharmalot March, 2011 Archive
Lawsuit Over J&J Risperdal Marketing Can Proceed
3 CommentsBy Ed Silverman // March 4th, 2011 // 3:33 pm
Most Docs Are Unaware Of FDA ‘Bad Ad’ Program
10 CommentsBy Ed Silverman // March 4th, 2011 // 11:26 am
All Eyes Are On Roche, Avastin And Lucentis
3 CommentsBy Ed Silverman // March 4th, 2011 // 10:44 am
Merck Discriminated Against A Non-Hispanic Worker?
2 CommentsBy Ed Silverman // March 4th, 2011 // 9:28 am
A Failed Study & A Higher Approval Bar For Amylin
2 CommentsBy Ed Silverman // March 3rd, 2011 // 12:22 pm
J&J’s Risperdal Consta Is Not Worth The Money?
2 CommentsBy Ed Silverman // March 3rd, 2011 // 7:46 am